Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2017
Home
2017
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Director’s Interest Notice – Maria Halasz
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Receives Australian Government Grant For Midkine Programme
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Notes to Appendix 4C
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
USA Midkine Alopecia Patent Allowed
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
European Midkine Alopecia Patent Allowed
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 4D and Half Year Accounts
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid to Refinance R&D Loan Facility
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmids FGF5 Inhibitor Clinical Study Published
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Notes to Appendix 4C
1
2
3
4
5
Next page
